Table 1.
Characteristic | All | Percentage |
---|---|---|
Age, years | ||
<66 (median) | 332 | 50 |
≥66 | 332 | 50 |
Sex | ||
Male | 363 | 55 |
Female | 301 | 45 |
Race | ||
White | 569 | 86 |
Other | 95 | 14 |
Disease stage | ||
I-IIIA | 296 | 41 |
IIIB, IV, recurrence | 333 | 59 |
Tumor histology | ||
Adenocarcinoma | 293 | 44 |
SCC and other | 371 | 56 |
Karnofsky Performance Status score | ||
<80 | 101 | 15 |
≥80 | 563 | 85 |
Induction chemotherapy | ||
No | 417 | 63 |
Yes | 247 | 37 |
Smoking status | ||
Never | 55 | 8 |
Former/current | 597 | 92 |
Total radiation dose, Gy | ||
<69.03 (median) | 328 | 50 |
≥69.03 | 330 | 50 |
GTV, cm3 | ||
<95.2 (median) | 306 | 50 |
≥95.2 | 305 | 50 |
MLD, Gy | ||
<17.9 (median) | 320 | 50 |
≥17.9 | 319 | 50 |
Radiation modality | ||
Photon (X-ray) | 511 | 77 |
Proton | 139 | 23 |
MUCB rs35705950 | ||
GG | 517 | 81 |
GT | 103 | 16 |
TT | 15 | 2 |